ℹ️
🇨🇿
Hledání
Hledat osoby relevantní k dotazu "In vitro antimycobacterial activity"
In vitro antimycobacterial activity
Osoba
Předm ěty
Osoby
Publikace
Studium
Exportovat aktuální pohled
RNDr. Eva Novotná Ph.D.
Akademický pracovník na Farmaceutická fakulta v Hradci Králové
63 publikací
Publikace
publication
Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase
2014 |
Farmaceutická fakulta v Hradci Králové
publication
Synthesis and in vitro antimycobacterial and isocitrate lyase inhibition properties of novel 2-methoxy-2'-hydroxybenzanilides, their thioxo analogues and benzoxazoles
2012 |
Farmaceutická fakulta v Hradci Králové
publication
Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues
2012 |
Farmaceutická fakulta v Hradci Králové
publication
Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo
2023 |
Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
publication
Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study
2022 |
Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
publication
Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter
2022 |
Farmaceutická fakulta v Hradci Králové
publication
Substituted N-phenylitaconamides as inhibitors of mycobacteria and mycobacterial isocitrate lyase
2022 |
Farmaceutická fakulta v Hradci Králové
publication
Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux
2022 |
Farmaceutická fakulta v Hradci Králové
publication
Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters
2022 |
Farmaceutická fakulta v Hradci Králové
publication
Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo
2021 |
Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
Načíst další publikace (53)
Loading network view...